Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Gandeeva’s $40 Million Series A Funding
Goodwin advised Gandeeva on the deal. Gandeeva announced its Series A funding led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures, Amgen Ventures,...
JMI Equity’s $85 Million Investment in ServiceTrade
Goodwin Procter advised JMI Equity on the deal. JMI Equity announced its $85 million growth investment in ServiceTrade. With the additional capital, ServiceTrade will increase the pace...